Portfolio of Gene Editing (CRISPR) Stocks
Here are 4 gene editing stocks that use CRISPR technology.
|4 Portfolio of Gene Editing (CRISPR) Stocks|
Stock & Price Chart
Recent Prices &
|Price data from Quandl as of most recent close.|
stocks are included in the portfolio computations. The current value of the portfolio assumes that $2,500.00 was invested (total of $10,000) in each stock at its closing monthly price for the current date in 2017. All prices are adjusted for splits and dividends.
To inspect the performance of the Portfolio of Gene Editing (CRISPR) Stocks portfolio, see the chart of portfolio below. Portfolio values are computed using monthly closes for stocks from Quandl.
The current value of a $10,000 investment is $16,658. The percent return is 66.58%. The annualized return is 24.45%.